Shared-Risk Pricing

We win when you win

The biggest bottleneck in clinical trials is effective patient recruitment.

The traditional model of database recruiting and focusing on quantity over quality just doesn’t work any more. Site staff are already over-worked and under-resourced—and asking them to perform additional screenings and qualify referrals that you paid for doesn’t make much sense.

Emphasizing shared-risk pricing leads to clearer communication, better outcomes, and higher quality referrals being sent to sites through the entire enrollment process.

What does shared-risk pricing mean?

Our pricing is based on specific milestones (such as signed ICFs or patient randomization) because like we said before—we win when you win.

Here’s why 1nHealth believes shared-risk pricing produces better outcomes for everyone in patient recruitment:

Confidence

Your goal is to meet enrollment targets on time and under budget. How does a list of leads that were qualified before we started working together help? Wouldn’t you rather only pay for patients who hit a specific milestone?

Flexibility

We establish benchmarks and analyze real-time data to make timely adjustments that maximize referrals. Rather than buying all media up front, we look for opportunities to adapt and improve based on how target audiences are responding.

Speed

When you only pay after patients hit a pre-determined milestone, we’re motivated to recruit with that in mind—not how many leads we can gather together or how long we can keep the recruitment campaign alive.

Partnership

All too often “free leads” come with the high operational costs because you have to qualify so many low-quality leads to hit enrollment. The process is inefficient and ineffective, and it puts an incredible amount of burden on sites.

1nHealth in action

Case study 04

1. Research

A COVID vaccine study asked 1nHealth to recruit 1,000 patients in one month for their COVID-19 registry. Participants needed a positive COVID test in the past 7 days, and there was no compensation for completing the survey.

2. Trial design

Ten days into the campaign, enrollments were ahead of schedule. Instead of ending the campaign early, 1nHeath offered a contract addendum to get the study additional enrollments towards the larger goal.

3. Trial management

1nHealth deployed ads on Facebook, Google, Snapchat and Pinterest, optimizing ad spend in real time, and ultimately allocating majority of the budget to highest-performing platform: Facebook.

Conclusion

The client opted to stop at 1,000 enrollments, so 1nHealth slowed ad spend. 1nHealth’s speed allowed for the option of additional enrollments to be produced ahead of the recruitment window.

Got any questions? We’d love to help.